The Pacific Coast Business Times reports on us!

July 13, 2015

In it's July 3-9 edition, the Pacific Cost Business Times reported on the pre-clinical study that we just completed on our malaria product, Artelutrine, a combination of active ingredients Artemisinin and Lumefantrine.

Please reload

All of us at Oak Therapeutics are extremely proud to announce that we just concluded initial preclinical testing of our anti-malarial medication Artel...

OAK THERAPEUTICS SUCCESSFULLY CONCLUDES TRIAL OF MALARIA MEDICATION

June 17, 2015

1/1

Please reload

Oak Therapeutics cooperates with KU Medical Center on HIV solutions

June 12, 2019

Oak Therapeutics receives NIH/NIAID contract

October 1, 2016

Oak Therapeutics in line for SBIR award

August 10, 2016

Oak Therapeutics receives Central Coast Innovation Award!

February 29, 2016

Listen to our co-founder Ed Maliski

January 2, 2016

The beginning of a vaccine - the end of malaria?

July 26, 2015

Oak Therapeutics Flip Book online

July 25, 2015

The Pacific Coast Business Times reports on us!

July 13, 2015

It's all about the children - video

July 10, 2015

Press Release: Oak enters battle against malaria

June 25, 2015

Please reload

June 2019 (1)

October 2016 (1)

August 2016 (1)

February 2016 (1)

January 2016 (1)

July 2015 (4)

June 2015 (2)

Please reload

The Pacific Coast Business Times reports on us!

Featured Posts

Recent Posts

Archive

Search By Tags

Follow Us